Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03983317 · ClinicalTrials.gov registry record · NA
Pilot Evaluation of the Empower Neuromodulation System in AUD Patients
A NA study, sponsored by Theranova, L.L.C..
- Completed
- Registry status
- NA
- Development phase
- 25
- Enrollment target
NCT03983317 is a NA study that has completed, run by Theranova, L.L.C.. The registered enrollment target is 25 participants.
The verdict
NCT03983317, a NA study, has completed, sponsored by Theranova, L.L.C..
- COMPLETED
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
Study Summary
This study evaluates the effects of peripheral nerve stimulation on alcohol craving and consumption in participants with alcohol use disorder (AUD). This is a pilot investigation in which all participants will receive the active treatment.
Interventions
- DEVICE Empower Neuromodulation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2019-05-20 |
| Est. Completion | 2020-03-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03983317
The ClinicalTrials.gov registry entry for NCT03983317 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Theranova, L.L.C., which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Empower Neuromodulation System is the first listed.
NCT03983317 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03983317 about?
NCT03983317 is a clinical study titled "Pilot Evaluation of the Empower Neuromodulation System in AUD Patients". This study evaluates the effects of peripheral nerve stimulation on alcohol craving and consumption in participants with alcohol use disorder (AUD). This is a pilot investigation in which all participants will receive the active treatment.
What is the current status of trial NCT03983317?
This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2019-05-20. Estimated completion is 2020-03-26.
What interventions are being tested in trial NCT03983317?
The interventions under investigation include: Empower Neuromodulation System (DEVICE).
Who is sponsoring clinical trial NCT03983317?
This trial is sponsored by Theranova, L.L.C., which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.